The abstract is read at the publisher; the summary is JClub's.
Soft robotic devices are emerging as promising alternatives in cardiovascular medicine, redefining three complementary frontiers: simulators, interventional instruments, and implants.
- Why it matters: Rigid cardiovascular simulators and therapeutic devices face limits in biomimetic fidelity, surgical invasiveness, and tissue-device mismatch, leaving unmet clinical needs.
- What they did: This Review matches clinical demands to technological advances and outlines soft robotic implementations across in vitro ventricular simulators and in vivo assistive simulators, percutaneous/endovascular/untethered instruments, and soft implants for vascular disease, arrhythmia, and heart failure.
- The result: The article describes advantages, applicable scope, and a translational roadmap for the coming decade, aiming to guide integration of soft robotics toward next-generation cardiac devices.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.